RT Journal Article
SR Electronic
T1 Exposure and risk factors for COVID-19 and the impact of staying home on Michigan residents
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.25.20181800
DO 10.1101/2020.08.25.20181800
A1 Kuan-Han H. Wu
A1 Whitney E. Hornsby
A1 Bethany Klunder
A1 Amelia Krause
A1 Anisa Driscoll
A1 John Kulka
A1 Ryan Bickett-Hickok
A1 Austin Fellows
A1 Sarah Graham
A1 Erin O. Kaleba
A1 Salim S. Hayek
A1 Xu Shi
A1 Nadia R. Sutton
A1 Nicholas Douville
A1 Bhramar Mukherjee
A1 Kenneth Jamerson
A1 Chad M. Brummett
A1 Cristen J. Willer
YR 2020
UL http://medrxiv.org/content/early/2020/08/31/2020.08.25.20181800.abstract
AB COVID-19 has had a substantial impact on clinical care and lifestyles globally. The State of Michigan reports over 80,000 positive COVID-19 tests between March 1, 2020 and July 29, 2020. We surveyed 8,047 Michigan Medicine biorepository participants in late June 2020. We found that 58% of COVID-19 cases reported no known exposure to family members or to someone outside the house diagnosed with COVID-19. A significantly higher rate of COVID-19 cases were employed as essential workers (45% vs 19%, p=3×10-11). COVID-19 cases reporting a fever were more likely to require hospitalization (categorized as severe; OR = 4.6 [95% CI: 1.7-13.0, p=0.004]) whereas respondents reporting rhinorrhea was less likely to require hospitalization (categorized as mild-to-moderate; OR = 0.16 [95% CI: 0.04-0.70, p=0.016]). African-Americans reported higher rates of being diagnosed with COVID-19 (OR = 4.0 [95% CI: 2.2-7.2, p=1×10-4]), as well as higher rates of exposure to family or someone outside the household diagnosed with COVID-19, an annual household income < $40,000, living in rental housing, and chronic diseases. During the Executive Order in Michigan, African Americans, women, and the lowest income group reported worsening health behaviors and higher overall concern for the potential detrimental effects of the pandemic. The higher risk of contracting COVID-19 observed among African Americans may be due to the increased rates of working as essential employees, lower socioeconomic status, and exposure to known positive cases. Continued efforts should focus on COVID-19 prevention and mitigation strategies, as well as address the inequality gaps that result in higher risks for both short-term and long-term health outcomes.Competing Interest StatementThe spouse of Dr. Willer works for Regeneron Pharmaceuticals Inc. Dr. Brummett is a consultant for Heron Therapeutics and Alosa Health -- not related to the present study.Funding StatementDr. Willer is supported by National Institutes of Health grants R35-HL135824, R01-HL142023, R01-DK075787, and R01-HL109946 Dr. Douville is supported by the Foundation for Anesthesia Education and Research (FAER) - Mentored Research Training Grant.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Michigan MED-IRB (HUM00180827)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available from the Data Office at the University of Michigan for IRB approved investigators.